Merk, T. | Search bioRxiv

bioRxiv2021

A spatio-spectral approach for movement decoding from cortical and subcortical recordings in patients with Parkinson's disease

The application of machine learning to intracranial signal analysis has the potential to revolutionize deep brain stimulation (DBS) by personalizing therapy to dynamic brain states, specific to symptoms and behaviors. Most decoding pipelines for movement decoding in the context of adaptive DBS are based on single channel frequency domain features, neglecting spatial information available in multichannel recordings. Such features are extracted either from DBS lead recordings in the subcortical target and/or from electrocorticography (ECoG). To optimize the simultaneous use of both types of signals, we developed a supervised online-compatible movement decoding pipeline based on multichannel and multiple site recordings. We found that adding spatial information to the model has the potential to improve decoding. In addition, we demonstrate movement decoding from spatio-spectral features derived from cortical and subcortical oscillations. We demonstrate between-patients variability of the spatial neural maps and its relationship to feature decoding performance. This application of spatial filters to decode movement from combined cortical and subcortical recordings is an important step in developing machine learning approaches for intelligent DBS systems.

neuroscience↗

bioRxiv2021

Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson's disease

Brain signal decoding promises significant advances in the development of clinical brain computer interfaces (BCI). In Parkinsons disease (PD), first bidirectional BCI implants for adaptive deep brain stimulation (DBS) are now available. Brain signal decoding can extend the clinical utility of adaptive DBS but the impact of neural source, computational methods and PD pathophysiology on decoding performance are unknown. This represents an unmet need for the development of future neurotechnology. To address this, we developed an invasive brain-signal decoding approach based on intraoperative sensorimotor electrocorticography (ECoG) and subthalamic LFP to predict grip-force, a representative movement decoding application, in 11 PD patients undergoing DBS. We demonstrate that ECoG is superior to subthalamic LFP for accurate grip-force decoding. Gradient boosted decision trees (XGBOOST) outperformed other model architectures. ECoG based decoding performance negatively correlated with motor impairment, which could be attributed to subthalamic beta bursts in the motor preparation and movement period. This highlights the impact of PD pathophysiology on the neural capacity to encode movement kinematics. Finally, we developed a connectomic analysis that could predict grip-force decoding performance of individual ECoG channels across patients by using their connectomic fingerprints. Our study provides a neurophysiological and computational framework for invasive brain signal decoding to aid the development of an individualized precision-medicine approach to intelligent adaptive DBS. Significance StatementNeurotechnology will revolutionize the treatment of neurological and psychiatric patients, promising novel treatment avenues for previously intractable brain disorders. However, optimal surgical and computational approaches and their interactions with neurological disorders are unknown. How can recent advances in machine learning and connectomics aid the precision and performance of invasive brain signal decoding strategies? Do the brain disorders treated with such approaches have impact on decoding performance? We propose a real time compatible advanced machine learning pipeline for invasively recorded brain signals in Parkinsons disease (PD) patients. We report optimal movement decoding strategies with respect to signal source, model architecture and connectomic fingerprint and demonstrate that PD pathophysiology significantly and negatively impacts movement decoding. Our study has broad impacts for the development of smart brain implants for the treatment of PD and other brain disorders.

neuroscience↗